Shinva Medical Secures Class II and III Device Approvals for Advanced Radiotherapy and Thoracoscopic Systems

Stock News
1 hour ago

Shinva Medical Instrument Co.,Ltd. (600587.SH) has announced that it recently received the Medical Device Registration Certificate from China's National Medical Products Administration, while its subsidiary, Shinva Surgical Instruments Co., Ltd., obtained a separate certificate from the Shandong Medical Products Administration.

The newly approved Class III device is the Respiratory Gating System, while the Class II device encompasses Thoracoscopic Surgical Instruments. As a cornerstone product in the field of precision radiotherapy, the Respiratory Gating System leverages real-time dynamic management of patients' respiratory motion to markedly improve targeting accuracy and therapeutic outcomes.

This system works in seamless tandem with the company's existing large-bore CT positioning equipment, enabling precise matching from initial localization through to treatment delivery, thereby reinforcing the firm's technological edge in comprehensive precision radiotherapy solutions. Thoracoscopic surgical instruments, which serve as fundamental and frequently utilized tools in thoracic surgery, complement the company's current medical endoscope camera systems and thoracoabdominal endoscopes, helping to round out its minimally invasive endoscopic surgery portfolio.

Upon obtaining these registrations, the company not only broadens its product lineup within the minimally invasive endoscopic arena but also elevates its overall competitiveness in thoracoscopic procedures, supporting expanded market reach and enhanced brand recognition.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10